Figure 4: Overview of the Four Vaccine Platform Technologies Considered by Operation Warp Speed, as of January 2021

Uploaded by U.S. Government Accountability Office
License United States Government Work
Comments 0
Favorites 0
Views 2,745
Date uploaded 2021-02-11
Tags gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao21319, operationwarpspeed, acip, advisorycommitteeonimmunizationpractices, barda, biomedicaladvancedresearchanddevelopmentauthority, bla, biologicslicenseapplication, cdc, centersfordiseasecontrolandprevention, cgmp, currentgoodmanufacturingpractice, covid19, coronavirusdisease2019, dod, departmentofdefense, eua, emergencyuseauthorization, fda, foodanddrugadministration, glp, goodlaboratorypractice, hhs, departmentofhealthandhumanservices, ind, investigationalnewdrug, mrna, messengerrna, ows, rd, researchanddevelopment, trl, technologyreadinesslevel, vrbpac, vaccinesandrelatedbiologicalproductsadvisorycommittee
Visibility public